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INTRODUCTION
Breast-conserving surgery (BCS) with radiation therapy is 
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Objective: To investigate preoperative magnetic resonance imaging (MRI) findings associated with resection margin status 
in patients with invasive lobular carcinoma (ILC) who underwent breast-conserving surgery.
Materials and Methods: One hundred and one patients with ILC who underwent preoperative MRI were included. MRI 
(tumor size, multifocality, type of enhancing lesion, distribution of non-mass enhancement [NME], and degree of background 
parenchymal enhancement) and clinicopathological features (age, pathologic tumor size, presence of ductal carcinoma in situ 
[DCIS] or lobular carcinoma in situ, presence of lymph node metastases, and estrogen receptor/progesterone receptor/human 
epidermal growth factor receptor type 2 status) were analyzed. A positive resection margin was defined as the presence of 
invasive cancer or DCIS at the inked surface. Logistic regression analysis was performed to determine pre- and postoperative 
variables associated with positive resection margins.
Results: Among the 101 patients, 21 (20.8%) showed positive resection margins. In the univariable analysis, NME, 
multifocality, axillary lymph node metastasis, and pathologic tumor size were associated with positive resection margins. 
With respect to preoperative MRI findings, multifocality (odds ratio [OR] = 3.977, p = 0.009) and NME (OR = 2.741, p = 0.063) 
were associated with positive resection margins in the multivariable analysis, although NME showed borderline significance.
Conclusion: In patients with ILC, multifocality and the presence of NME on preoperative breast MRI were associated with 
positive resection margins.
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the standard treatment for early-stage invasive breast cancer, 
and there is no significant difference in survival outcome 
between patients who undergo mastectomy and those who 
undergo BCS after 20 years of follow-up (1, 2). However, 
positive resection margins after BCS still pose difficulties 
in patient management. Positive resection margins are 
associated with a two-fold increase in the risk of ipsilateral 
breast tumor recurrence compared with negative margins 
(3). Consequently, almost 25% of patients who undergo BCS 
require additional re-excisions (4, 5).
Magnetic resonance imaging (MRI) has been reported to 
be more sensitive than mammography in detecting invasive 
cancer or ductal carcinoma in situ (DCIS), and is known to 
be more accurate than mammography or ultrasonography (US) 
in determining tumor diameters and margins and detecting 
multifocal, multicentric, and synchronous contralateral 
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breast cancers (6-8). Several studies have investigated 
preoperative MRI features associated with resection margin 
status in invasive breast cancer, and reported that non-mass 
enhancement (NME) and less convex margins are associated 
with positive resection margins (9, 10).
However, these results were based on study populations 
composed mostly of patients with invasive ductal carcinoma 
(IDC) (9, 10). Furthermore, the majority of malignant 
NME lesions depicted by MRI in previous studies were 
confirmed as DCIS, so the sensitivity advantage of MRI over 
conventional imaging in depicting local tumor extent was 
reported to increase as DCIS component size increased, 
which would be less frequently detected in invasive lobular 
carcinoma (ILC) (11, 12). Therefore, it is unclear whether 
similar MRI features are associated with resection margin 
status in this subgroup.
Although the association between preoperative MRI 
and surgical outcomes in patients with breast cancer 
is still under debate, multiple studies have shown that 
preoperative MRI can significantly reduce re-excision rates 
after initial surgery in patients with ILC (13-16). Such 
results have been incorporated into recommendations 
from the European Society of Breast Cancer Specialists 
working group and the U.S. National Comprehensive Cancer 
Network guidelines (17, 18), in which preoperative MRI 
is recommended for patients with ILC and several other 
subgroups of patients with breast cancer.
However, to the best of our knowledge, no studies have 
reviewed specific preoperative MRI features related to 
surgical outcomes in patients with ILC. Despite the improved 
accuracy of MRI in demonstrating tumor extent, the 
increasing incidence of BCS is less clear in patients with ILC 
compared with those with IDC (19). Further identification 
of imaging features related to resection margin status 
would aid in patient management by enhancing confidence 
in performing BCS for ILC patients at low risk for positive 
margins, and identifying patients at high risk for re-excision 
who may require more aggressive surgery.
Therefore, the purpose of this study was to investigate 
preoperative MRI findings associated with resection margin 
status in patients with ILC.
MATERIALS AND METHODS
Patients
Our Institutional Review Board approved this retrospective 
study and waived the requirement to obtain informed 
consent. We conducted a retrospective chart review and 
identified 197 consecutive patients with newly diagnosed 
ILC who underwent preoperative MRI and surgery from May 
2012 to August 2017. Patients who underwent vacuum-
assisted biopsy (n = 4), surgical excisional biopsy (n = 2), 
or neoadjuvant chemotherapy before MRI (n = 17) were 
excluded. Among the remaining 174 patients, 73 patients 
who underwent total mastectomy were excluded. Finally, 
101 patients (mean age, 52.1 years; range, 34–76 years) 
who underwent BCS were included in this study (Fig. 1). 
Histopathologic Analysis
Pathologic data including pathologic tumor size, histologic 
grade, estrogen receptor (ER)/progesterone receptor (PR)/
human epidermal growth factor receptor type 2 (HER2) 
status, and presence of metastasis in surgically resected 
axillary lymph nodes were obtained from the final pathologic 
reports. A tumor was considered ER/PR-positive when 10% 
of tumor cells in the testing sample had positively stained 
nuclei (20). The immunohistochemical staining results 
for HER2 were scored as 0, 1+, 2+, or 3+ according to the 
number of cells with positively stained membranes. Tumors 
with a score of 0 or 1+ were classified as HER2-negative, 
whereas tumors with a score of 3+ were classified as HER2-
positive. In tumors with a score of 2+, additional gene 
amplification using silver in situ hybridization was performed 
to determine HER2 status. HER2 positivity was defined as a 
HER2/chromosome 17 ratio greater than 2.0 (21).
Lesion Localization and Assessment of the Resection 
Margin
Preoperative wire localization of non-palpable lesions 
was performed with mammogram or US guidance. In all 
cases, intraoperative margin excision and frozen section 
analysis were performed. According to the Society of 
Surgical Oncology-American Society for Radiation Oncology-
American Society of Clinical Oncology consensus guideline 
(22), a “positive resection margin” was defined as the 
presence of invasive cancer or DCIS at the inked surface 
of the resected specimen, in either the frozen section or 
permanent specimen. The presence of lobular carcinoma in 
situ (LCIS) at the inked surface was considered to indicate a 
negative resection margin. 
MRI Technique
Breast MRI examinations were performed using one 




Milwaukee, WI, USA) or Ingenia (Philips Healthcare, Best, 
The Netherlands). Patients lay in the prone position, and 
imaging was performed with a dedicated phased array breast 
coil (8-channel [GE Healthcare] or 16-channel [Philips 
Healthcare]). Before the contrast agent was injected, a 
three-plane localizing sequence, axial T2-weighted fast spin 
echo and T2-stimulated inversion recovery sequence, and 
axial T1-weighted sequence with/without fat suppression 
were obtained. A bolus injection of a gadolinium-based 
contrast agent (Dotarem [gadoterate meglumine], Guerbet, 
Paris, France; Magnevist [gadopentetate dimeglumine], 
Berlex Laboratories, Wayne, NJ, USA; or Gadovist 
[gadobutrol], Bayer AG, Berlin, Germany) at a dose of 0.2 
mmol/kg was administered at a rate of 2 mL/s, followed 
by a 20 mL saline flush. After the contrast agent was 
injected, T1-weighted three-dimensional (3D) dynamic 
contrast-enhanced images were acquired in the axial plane. 
This included one pre-contrast acquisition and six post-
contrast bilateral axial acquisitions. Post-contrast images 
were obtained immediately after the contrast material was 
injected with no time delay. The length of each dynamic 
series was 63 (Discover 750) or 64 seconds (Ingenia). 
T1-weighted 3D delayed post-contrast images were later 
obtained in the sagittal plane. Image subtraction was 
performed after the dynamic series, including subtraction 
of the pre-contrast images from the 1st, 2nd, and 6th post-
contrast images.
Image Analysis
One board certified, breast-dedicated radiologist with 5 
years of subspecialty experience in breast imaging reviewed 
the breast MR images according to the American College 
of Radiology Breast Imaging-Reporting and Data System 
(23). Tumor size was defined as the maximal diameter of 
the enhancing tumor on the early post-contrast subtraction 
images, which were obtained by subtracting the pre-
contrast images from the 2nd post-contrast images acquired 
approximately 2 minutes after contrast material injection. 
Multifocal disease was defined as findings suspicious of 
additional sites of malignancy within the same quadrant 
as the index cancer. Enhancing lesions were divided into 
masses or NME. We further categorized the 101 cases into 
masses without NME and NME with or without a mass. In 
patients with NME, we analyzed NME distribution (focal, 
linear, or segmental). Background parenchymal enhancement 
(BPE) was categorized as minimal, mild, moderate, or 
marked based on a combination of pre-contrast, 2nd post-
contrast T1-weighted images and subtraction images (23). 
After categorization, we dichotomized BPE into weak 
(minimal or mild) and strong (moderate or marked). 
Patients with newly diagnosed invasive lobular carcinoma who underwent preoperative MRI and
surgery from May 2012 to August 2017 (n = 197)
174 patients
73 patients who underwent total mastectomy
• Underwent vacuum-assisted biopsy (n = 4)
• Underwent surgical excisional biopsy (n = 2)
• Underwent neoadjuvant chemotherapy before MRI (n = 17)
Included (n = 101)
Invasive cancer or DCIS





Fig. 1. Patient selection diagram. DCIS = ductal carcinoma in situ, MRI = magnetic resonance imaging
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Statistical Analysis
The patients were divided into two groups according to 
resection margin status. Clinicopathological variables and 
imaging features were compared between the groups using 
the chi-square test or Fisher’s exact test for categorical 
variables and the independent t test for continuous 
variables. Univariable logistic regression analysis was used 
to identify variables associated with positive resection 
margins. Multivariable logistic regression analysis was used 
to identify preoperative variables significantly associated 
with positive resection margins, using only preoperative 
variables that showed a significant association (p < 0.05) 
in the univariate analysis. Additional multivariable logistic 
regression analysis was performed using preoperative 
and postoperative variables that showed a significant 
association (p < 0.05) in the univariate analysis. All 
statistical analyses were performed using SPSS version 
23.0.0 (IBM Corp., Armonk, NY, USA), and a p value < 0.05 
was considered statistically significant.
RESULTS
The mean pathologic tumor size was 15.2 mm (standard 
deviation, 8.9 mm; range, 3–43 mm). Among the 101 
patients, 11 (10.8%) had combined DCIS and 62 (61.4%) had 
combined LCIS. Negative resection margins were achieved in 
all of the patients with combined DCIS. Of the 101 patients, 
15 (14.9%) had axillary lymph node metastasis.
Among the 101 patients, 21 (20.8%) showed positive 
resection margins. Among the 21 patients with positive 
resection margins, 9 (42.9%) were converted to mastectomy 
at the time of the initial operation, 11 (52.4%) underwent 
additional local excision at the time of the initial 
operation, and 1 (4.8%) underwent re-excision later. Of 
the 11 patients who underwent immediate additional local 
excision, 3 (27.3%) later underwent mastectomy due to a 
positive margin on the re-excision specimen. Therefore, 12 
(57.1%) of the 21 patients with positive resection margins 
were eventually converted to mastectomy (Figs. 2, 3).
Fig. 2. 71-year-old female with invasive lobular carcinoma at left upper breast.
A, B. Preoperative axial early contrast-enhanced T1-weighted subtraction MR images show malignant mass at left upper medial breast (arrow in 
A) with adjacent suspicious non-mass enhancement (long arrow in B) and additionally detected suspicious focus at left subareolar breast (short 
arrow in B). At breast-conserving surgery, positive resection margin was confirmed on intraoperative frozen sectional analysis and additional 
local excision was performed immediately.
A B
Fig. 3. 48 year-old female with invasive lobular carcinoma at 
right upper outer breast. Preoperative axial early contrast-enhanced 
T1-weighted subtraction MR image show suspicious non-mass 
enhancement at right upper outer breast (arrow). At breast-conserving 
surgery, positive resection margin was confirmed by intraoperative 





When comparing MRI features between the positive and 
negative resection margin groups, the presence of NME 
(NME with/without mass) showed significant difference 
between the two groups (47.6% vs. 21.3%, p = 0.015). 
The incidence of multifocality on preoperative breast MRI 
also showed significant difference between the two groups 
(57.1% vs. 22.5%, p = 0.002). The mean pathologic tumor 
size was significantly larger in the positive resection margin 
group (22.3 ± 10.5 mm vs. 13.4 ± 7.5 mm, p < 0.001), and 
patients with positive resection margins had a higher rate 
of pathologic lymph node metastasis (38.1% vs. 8.8%, p = 
0.003) (Table 1).
In the univariable logistic regression analysis, NME 
on preoperative breast MRI (odds ratio [OR] = 3.369; 
95% confidence interval [CI] = 1.227–9.251; p = 0.018), 
multifocality on preoperative breast MRI (OR = 4.593; 
95% CI = 1.671–12.623; p = 0.003), pathologic tumor 
size (OR = 1.117; 95% CI = 1.052–1.186; p < 0.001), and 
Table 1. Comparison of Variables according to Status of Resection Margin
Characteristics Positive Resection Margin (n = 21) Negative Resection Margin (n = 80) P
Age (years) 49.6 ± 8.9 52.8 ± 10.0 0.193
Pathologic tumor size (mm) 22.3 ± 10.5 13.4 ± 7.5 < 0.001
DCIS present 0.114
Yes 0 (0.0) 11 (13.8)
No 21 (100.0) 69 (86.3)
LCIS present 0.288
Yes 15 (71.4) 47 (58.8)
No 6 (28.6) 33 (41.3)
Lymph node metastases 0.003
Yes 8 (38.1) 7 (8.8)
No 13 (61.9) 73 (91.3)
Estrogen receptor > 0.999
Positive 20 (95.2) 75 (93.8)
Negative 1 (4.8) 5 (6.3)
Progesterone receptor > 0.999
Positive 17 (81.0) 64 (80.0)
Negative 4 (19.0) 16 (20.0)
HER2 0.635
Positive 2 (9.5) 5 (6.3)
Negative 19 (90.5) 75 (93.8)
Wire localization > 0.999
Yes 17 (81.0) 64 (80.0)
No 4 (19.0) 16 (20.0)
Size on MRI (mm) 20.1 ± 9.4 17.6 ± 8.5 0.234
BPE 0.368
Weak 15 (71.4) 65 (81.3)
Strong 6 (28.6) 15 (18.8)
Presence of NME 0.015
Yes 10 (47.6) 17 (21.3)
No 11 (52.4) 63 (78.8)
Distribution of NME 0.290
Focal 5 (50.0) 12 (70.6)
Linear/segmental 5 (50.0) 5 (29.4)
Multifocality 0.002
Yes 12 (57.1) 18 (22.5)
No 9 (42.9) 62 (77.5)
Unless otherwise indicated, data in parentheses are percentages. BPE = background parenchymal enhancement, DCIS = ductal carcinoma 
in situ, HER2 = human epidermal growth factor receptor type 2, LCIS = lobular carcinoma in situ, MRI = magnetic resonance imaging, 
NME = non-mass enhancement
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axillary lymph node metastasis (OR = 6.418; 95% CI = 
1.985–20.750; p = 0.002) were significantly associated with 
positive resection margins (Table 2).
In the multivariable logistic regression analysis of 
preoperative variables, multifocality on preoperative breast 
MRI was independently associated with positive resection 
margins (OR = 3.977; 95% CI = 1.408–11.231; p = 0.009). 
NME on preoperative breast MRI tended to be associated 
with positive resection margins but showed borderline 
significance (OR = 2.741; 95% CI = 0.948–7.925; p = 0.063) 
(Table 3). 
In the multivariable logistic regression analysis of 
pre- and postoperative variables, only multifocality on 
preoperative breast MRI (OR = 3.263; 95% CI = 1.034–
10.304; p = 0.044) and pathologic tumor size (OR = 1.092; 
95% CI = 1.023–1.166; p = 0.008) were independently 
associated with positive resection margins (Table 3).
DISCUSSION
In our study, we found that multifocality on preoperative 
breast MRI was independently associated with positive 
resection margins in patients with ILC, whereas NME showed 
borderline significance. The rate of positive resection 
margins in our study was 20.8% (21/101), which was 
within the previously reported range of 20–70% (24, 25). 
As preoperative MRI is recommended for patients with ILC 
(17, 18), our study results could provide assurance in cases 
which are unlikely to yield positive margins at BCS, help 
identify high-risk cases in which the extent of resection 
should be increased, and allow patients to be warned about 
the higher likelihood of additional procedures being needed 
to attain negative margins.
Although ILC is the second most common histological 
subtype of breast cancer, it is more challenging clinically 
and radiologically to detect than IDC (26). Due to its 
infiltrative nature, both mammography and US show lower 
sensitivity in depicting ILC, and MRI has been shown to be 
particularly useful in the assessment of tumor extent in this 
subgroup (26). However, surgeons may still prefer to adopt 
a more aggressive local approach for these patients, mainly 
due to the higher risk of incomplete resection with BCS (19). 
In the past five years, several studies have reported that 
preoperative MRI can reduce re-excision rates in patients 
with ILC, but none has reviewed the MRI features of ILC 
related to surgical outcomes (13-16). 
In past studies with study populations composed mostly 
of patients with IDC, NME on preoperative MRI, tumor 
size exceeding 5 cm, and multifocal lesions were factors 
associated with positive resection margins after BCS (9, 27, 
28). As DCIS lesions commonly appear as NME on MRI (29, 
30), previous studies suggested an association between DCIS 
components and positive resection margins (12). In one 
study, 55% (22/40) of the NME lesions around index cancer 
masses were malignant, with 81.8% (18/22) confirmed 
as DCIS (11). In addition, as DCIS commonly presents as 
microcalcifications on mammography (31), previous studies 
Table 2. Univariate Logistic Regression Analysis of Variables 
for Predicting Positive Resection Margins
Variables OR 95% CI P
Pathologic tumor size (mm) 1.117 1.052–1.186 < 0.001
DCIS present
Yes 0.000 0.000–0.000 0.999
No Ref
LCIS present
Yes 1.755 0.617–4.997 0.292
No Ref
Lymph node metastases
Yes 6.418 1.985–20.750 0.002
No Ref
Estrogen receptor
Positive 1.333 0.147–12.069 0.798
Negative Ref
Progesterone receptor
Positive 1.062 0.314–3.596 0.922
Negative Ref
HER2
Positive 1.558 0.280–8.661 0.613
Negative Ref
Wire localization
Yes 1.062 0.314–3.596 0.922
No Ref
Size on MRI (mm) 1.033 0.979–1.089 0.234
BPE
Weak Ref
Strong 1.733 0.577–5.211 0.327
Presence of NME
Yes 3.369 1.227–9.251 0.018
No Ref




Yes 4.593 1.671–12.623 0.003
No Ref




have reported that the presence of microcalcifications on 
mammography and presence of DCIS were both associated 
with resection margin status in patient populations 
composed mostly of patients with IDC (32).
In this study, we questioned whether similar MRI features 
were also associated with resection margin status in 
patients with ILC. Of the 101 patients included in our study, 
11 (10.8%) had combined DCIS, but negative resection 
margins were achieved in all of these patients. However, 
our study results showed that multifocality and NME on 
preoperative MRI were associated with positive resection 
margins in ILC patients, although NME showed borderline 
significance. Tumors with higher cellularity usually present 
as masses, whereas scattered tumor cells and tumors with 
lower cellularity present as NME, which may underlie the 
association between NME and resection margin status (33). 
Among the enhancing patterns of ILC on MRI, NME has 
been correlated with malignant cells streaming in a single-
file fashion in the breast stroma or small tumor aggregates 
separated by normal tissue, which would likely cause 
underestimation of tumor extent (34, 35). Our results are 
also consistent with previous studies, which have reported 
that NME lesions show higher discordance than mass lesions 
in estimating tumor size (36). 
In addition, the lack of MRI-guided lesion localization 
may have also attributed to the higher positive resection 
margin rate in NME lesions. Although previous trials 
investigating the benefit of breast MRI for treatment 
planning in women with invasive breast cancer have failed 
to demonstrate a positive effect on surgical outcome, 
one recent study that utilized MRI-guided biopsy and 
MRI-guided lesion bracketing demonstrated a low overall 
positive margin rate of 3.7% (12). Therefore, we can infer 
that in real-world clinical practice where the use of MRI-
guided lesion localization is often lacking, the improved 
assessment of tumor extent by MRI may not be fully 
applicable to surgery. This would be especially related 
to NME, which is often less discernible on conventional 
imaging (37). 
ILC has been associated with higher rates of positive 
resection margins after BCS compared to IDC (38, 39). In 
a previous study that focused on the associations between 
clinicopathologic variables and positive resection margins, 
tumor size exceeding 2 cm and lymph node involvement 
were associated with positive resection margins in ILC (40). 
Our study showed similar results, with multifocality at MRI 
and tumor size being independently associated with positive 
resection margins. Axillary lymph node metastasis was 
also associated with positive resection margins, although 
this was not statistically significant in the multivariable 
analysis. Our study results imply that multifocality on MRI 
and tumor size are most strongly associated with positive 
margins in patients with ILC, for whom more aggressive 
surgery such as resection of shave margins, wide excision, 
or mastectomy should be considered. Patients with none of 
these risk factors and without NME on MRI have a lower risk 
of positive margins and may more confidently receive BCS.
There are several limitations of this study. First, this 
was a retrospective study and patients were recruited 
from a single tertiary referral center, so selection bias 
was inevitable. Second, one breast-dedicated radiologist 
reviewed the breast MR images. Although a high agreement 
rate among readers has been reported when differentiating 
NME from mass lesions, interobserver variability would 
be present if another radiologist were to review the same 
images (41). Third, our study had a small number of events 
Table 3. Multivariate Analysis of Pre/Postoperative Variables for Predicting Positive Resection Margins
Preoperative Variables Pre/Postoperative Variables
Variables OR 95% CI P Variables OR 95% CI P
Presence of NME Presence of NME
Yes 2.741 0.948–7.925 0.063 Yes 1.805 0.543–6.000 0.335
No Ref No Ref
Multifocality Multifocality
Yes 3.977 1.408–11.231 0.009 Yes 3.263 1.034–10.304 0.044
No Ref No Ref
Pathologic tumor size (mm) 1.092 1.023–1.166 0.008
Lymph node metastases
Yes 2.735 0.676–11.065 0.158
No Ref
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(21 cases with positive resection margins), which may have 
caused overfitting of the model. An event per variable ≥ 
10 would be preferable, and larger studies are required to 
confirm our results (42).
In conclusion, in patients with ILC, multifocality and NME 
on preoperative breast MRI were associated with positive 
resection margins. These findings may aid in determining 
the extent of resection required prior to BCS.
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